Clinical Study on Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in the Treatment of Acute Myeloid Leukemia
Clinical trial NCT05943314 · WITHDRAWN
Trial details
- NCT number
- NCT05943314
- Sponsor
- Guangzhou Bio-gene Technology Co., Ltd
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-12
- Primary completion
- 2023-08-28
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.